Fatty acids – 1. Occurrence and biological significance
Authors:
E. Tvrzická; B. Staňková; M. Vecka; A. Žák
Authors‘ workplace:
Univerzita Karlova v Praze, 1. lékařská fakulta, IV. interní klinika
Published in:
Čas. Lék. čes. 2009; 148: 16-24
Category:
Review Article
Overview
Fatty acids are monocarboxylic acids with chain-length 2–36 carbon atoms and 0–6 double bonds. Their physico-chemical properties are reflected also in the compounds, where fatty acids represent an important component (phospholipids, triglycerides), as well as in higher organized structures (plasma membranes, lipoproteins). Fatty acids are synthesized from two-carbon precursors; their degradation by ß-oxidation is accompanied by energy-release. Fatty acids are classified with respect to double bonds into saturated, monounsaturated and polyunsaturated. Simple lipids are esters of fatty acids and organic alcohols – cholesterol, glycerol and sphingosine and their derivatives. Endogenous acids can be desaturated up to ∆9 position; desaturation to other position is possible only from exogenous (essential) acids [(linoleic (n-6 series) and α-linolenic (n-3 series)]. Circulating lipids (in form of lipoproteins) consist of cholesterol esters and triglycerides in nonpolar core and phosphatidylcholin and sphingomyelin in the polar envelope of lipoproteins. Nonesterified fatty acids (product of lipolysis and source for lipid synthesis) are bound to plasma albumin. Membrane lipids, which ensure membrane fluidity and other functions, consist of phosphatidylcholine, phosphatidylethanolamine, sphingomyelin and some other (minor) phospholipids.
Key words:
fatty acids, lipids, lipoproteins, metabolism.
Sources
1. Nelson DL, Cox MM. Lipid Biosynthesis. In: Principles of Biochemistry. New York: W.H. Freeman and Comp. 2005; 787–815.
2. Gunstone FD. Fatty Acid Structure. In The Lipid Handbook. London: Chapman and Hall 1994; 1–19.
3. Larsson K, Quinn PJ. Physical Properties: Structural and Physical Characteristics. In The Lipid Handbook. London: Chapman and Hall 1994; 401–465.
4. De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 2008; 3: 133–149.
5. Mead JF. The metabolism of polyunsaturated fatty acids. In Holman RT. Progress in the Chemistry of Fats and Other Lipids. Oxford: Pergamon Press 1971; 161–189.
6. Compher C, Setto RW, Lew JI, et al. Dietary fiber and its Clinical Applications to Enteral Nutrition. In Rombeau JL, Rolandelli RH. Clinical Nutrition: Enteral and Tube Feeding. Philadelphia: W.B. Saunders Comp. 1997; 81–95.
7. Hainer V, Kunešová M, Štich V, et al. Úloha olejů s obsahem triglyceridů s mastnými kyselinami o středním řetězci v dietní léčbě otylosti. Vliv na klidový energetický výdej a sérové lipidy. Čas Lék čes 1994; 133: 373–375.
8. Larsson K, Quinn PJ. Occurence and Characteristics of Oils and Fats. In The Lipid Handbook. London: Chapman and Hall 1994; 47–223.
9. Vemuri M, Kelley DS. The Effects of Dietary Fatty Acids on Lipid Metabolism. In Chow CK. Fatty Acids in Foods and Their Health Implications. Boca Raton: CRC Press 2007; 591–630.
10. Ulbright TLV, Southgate DAT. Coronary heart disease: seven dietary factors. Lancet 1991; 338: 985–992.
11. Gotto AM. Contemporary diagnosis and management of lipid disorders. Newtown, Pa.: Handbooks in Health Care Co. 2004.
12. Beare-Rogers JL, Nera EA. Cardiac fatty acids and histopathology of rats, pigs, monkeys and gerbils fed rapeseed oil. Comp Biochem Physiol B 1972; 41: 793–800.
13. Stöckler S, Opper C, Greinacher A, et al. Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides. J Inherit Metab Dis 1997; 20: 54–58.
14. Richardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004; 23: 447–456.
15. Osso FS, Moreira AS, Teixeira MT, et al. Trans fatty acids in maternal milk lead to cardiac insulin resistance in adult offspring. Nutrition 2008; 24: 727–732.
16. Booker CS, Mann JL. Trans fatty acids and cardiovascular health: translation of the evidence base. Nutr Metab Cardiovasc Dis 2008; 18: 448–456.
17. Staels B. The PPAR System and Regulation of Lipoprotein Metabolism. In Betteridge DJ. Lipids and vascular disease. London: Martin Dunitz Publ 2000; 27–37.
18. Schoonjans K, Martin G, Staels B, et al. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 1997; 8: 159–166.
19. Vergroesen AJ. Essential fatty Acids, Biomembranes and Eicosanoid Metabolism. In Vergroesen AJ, Crawford M. The role of fats in human nutrition. London: Academic Press 1989; 17–29.
20. Brenna TJ. Efficiency of conversion of [alpha]-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002; 5: 127–132.
21. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438–463.
22. Burdge G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implication. Curr Opin Clin Nutr Metab Care 2004; 7: 137–144.
23. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003; 38: 343–352.
24. Lawson RE, Moss AR, Ian Givens D. The role of dairy products in supplying conjugated linoleic acid to man’s diet: A review. Nutr Res Rev 2001; 14: 153–172.
25. Pariza MW, Hargraves WA. A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12 dimethylbenz[a]anthracene. Carcinogenesis 1985; 6: 591–593.
26. Pineda Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol 1999; 10: 151–159.
27. Tvrzická E, Vecka M, Žák A. Konjugovaná kyselina linoleová – dietní suplement v prevenci kardiovaskulárních onemocnění? Čas Lék čes 2007; 146: 459–465.
28. Harwood JL. Lipid Structure. In The Lipid Handbook. London: Chapman and Hall 1994; 21–46.
29. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–1353.
30. Zuijdgeest-van Leeuwen SD, van der Heijden MS, Veld TR, et al. Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr 2002; 21: 225–230.
31. Tvrzická E, Vecka M, Staňková B, et al. Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionization detection Quantitative aspects. Anal Chim Acta 2002; 465: 337–350.
32. de Almeida IT, Cortez-Pinto H, Hidalgo G, et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 2002; 21: 219–223.
33. Nelson DL, Cox MM. Biological Membranes and Transport. In: Principles of Biochemistry. New York: W.H. Freeman and Comp. 2005; 369–420.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Fatty acids – 1. Occurrence and biological significance
- Osteoporosis: Whom, when and how to treat?
- Coffee, its legend, history, and influence on human health
- Nitric oxide in patients with obesity and metabolic syndrome